We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
-6.56%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$855M
AUM Growth
+$250M
Cap. Flow
+$327M
Cap. Flow %
38.29%
Top 10 Hldgs %
13.1%
Holding
788
New
316
Increased
155
Reduced
106
Closed
211

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$13.6M
2
MRK icon
Merck
MRK
+$12.5M
3
ISRG icon
Intuitive Surgical
ISRG
+$11.1M
4
DOCU
DocuSign
DOCU
+$10.9M
5
PODD icon
Insulet
PODD
+$10.8M

Top Sells

Rank Stock Value
1
NDAQ icon
Nasdaq
NDAQ
+$7.26M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$6.86M
3
INCY icon
Incyte
INCY
+$6.31M
4
FIS icon
Fidelity National Information Services
FIS
+$5.73M
5
ABBV icon
AbbVie
ABBV
+$4.95M

Sector Composition

Rank Sector Weight
1 Technology 20.41%
2 Consumer Discretionary 17.68%
3 Healthcare 16.13%
4 Industrials 12.13%
5 Financials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EW icon
1
Edwards Lifesciences
EW
$48.2B
$12.3M 1.44%
177,128
+169,746
+2,299% +$13.6M
MRK icon
2
Merck
MRK
$325B
$11.9M 1.39%
+115,677
New +$12.5M
LVS icon
3
Las Vegas Sands
LVS
$31.9B
$11.9M 1.39%
258,673
+165,470
+178% +$8.94M
MSFT icon
4
Microsoft
MSFT
$2.95T
$11.8M 1.38%
37,260
+15,879
+74% +$5.25M
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.09T
$11.7M 1.37%
88,776
+28,838
+48% +$3.75M
VRTX icon
6
Vertex Pharmaceuticals
VRTX
$124B
$11.7M 1.36%
33,544
+23,206
+224% +$8.12M
VRT icon
7
Vertiv
VRT
$102B
$11.1M 1.3%
298,220
+207,111
+227% +$6.83M
ISRG icon
8
Intuitive Surgical
ISRG
$130B
$10.6M 1.24%
36,371
+35,397
+3,634% +$11.1M
RMD icon
9
ResMed
RMD
$30.3B
$9.75M 1.14%
65,934
+39,999
+154% +$7.23M
DOCU
10
DocuSign
DOCU
$10.7B
$9.35M 1.09%
+222,732
New +$10.9M
FISV
11
Fiserv Inc
FISV
$29B
$9.17M 1.07%
81,147
+67,488
+494% +$8.31M
XYL icon
12
Xylem
XYL
$29.6B
$9.1M 1.06%
+99,940
New +$10.3M
META icon
13
Meta Platforms (Facebook)
META
$1.51T
$8.98M 1.05%
+29,913
New +$9.01M
JBL icon
14
Jabil
JBL
$31.6B
$8.77M 1.03%
69,103
+49,625
+255% +$5.43M
NEE icon
15
NextEra Energy
NEE
$186B
$8.56M 1%
+149,492
New +$10.3M
SBUX icon
16
Starbucks
SBUX
$117B
$8.46M 0.99%
92,661
+64,724
+232% +$6.35M
HPQ icon
17
HP
HPQ
$25.7B
$7.89M 0.92%
+306,903
New +$9.42M
VST icon
18
Vistra
VST
$50.1B
$7.88M 0.92%
+237,467
New +$7.13M
PODD icon
19
Insulet
PODD
$11.7B
$7.86M 0.92%
49,267
+48,408
+5,635% +$10.8M
DG icon
20
Dollar General
DG
$27.8B
$7.28M 0.85%
68,815
+51,695
+302% +$7.71M
IPG
21
DELISTED
Interpublic Group of Companies
IPG
$6.88M 0.8%
+239,909
New +$8.01M
ALLY icon
22
Ally Financial
ALLY
$13.5B
$6.67M 0.78%
+250,062
New +$6.98M
PLTR icon
23
Palantir
PLTR
$296B
$6.54M 0.77%
409,037
+65,824
+19% +$1.05M
TGT icon
24
Target
TGT
$65.4B
$6.29M 0.74%
56,914
+16,782
+42% +$2.13M
STT icon
25
State Street
STT
$49.9B
$5.89M 0.69%
87,933
+66,656
+313% +$4.7M
1
2 3 4 5

Similar funds

PP
Pegasus Partners Mequon, Wisconsin $1.07B AUM 32.32% 1-Year Est. Return
ECM
Ensemble Capital Management San Francisco, California $1.18B AUM 41.81% 1-Year Est. Return
GCAC
Guardian Capital Advisors (Canada) Toronto, Ontario, Canada $1.02B AUM 25.29% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return
D
Diversified Wilmington, Delaware $911M AUM 31% 1-Year Est. Return
GFS
GYL Financial Synergies West Hartford, Connecticut $1.33B AUM 34.46% 1-Year Est. Return
FTIS
First Trust Investment Solutions Naples, Florida $888M AUM 34.3% 1-Year Est. Return
AIA
Alera Investment Advisors Deerfield, Illinois $851M AUM 29.76% 1-Year Est. Return

Seven Eight Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Seven Eight Capital held 788 positions worth $855M, up 41% from $605M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Seven Eight Capital deployed $327M of net new capital in Q3 2023, opening 316 new positions and adding to 155 existing holdings. Its largest new stake was Merck: 115,677 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $6.86M trimmed.

  • Seven Eight Capital's largest Q3 2023 buy was Merck: 115,677 shares worth $11.9M.
  • Seven Eight Capital added most to Edwards Lifesciences in Q3 2023, an estimated $13.6M increase.
  • Seven Eight Capital's biggest Q3 2023 reduction was BioMarin Pharmaceuticals, cutting an estimated $6.86M.
  • Seven Eight Capital fully exited Nasdaq in Q3 2023, selling an estimated $7.26M.
  • Seven Eight Capital's ten largest holdings make up 13% of its $855M portfolio in Q3 2023.
  • Seven Eight Capital opened 316 new positions and closed 211 in Q3 2023.
  • Seven Eight Capital's portfolio value rose 41% quarter-over-quarter to $855M.

Based on Seven Eight Capital's 13F filing for Q3 2023, filed 14 Nov 2023.